331 related articles for article (PubMed ID: 17521872)
1. Impact of an absorbent silver-eluting dressing system on lower extremity revascularization wound complications.
Childress BB; Berceli SA; Nelson PR; Lee WA; Ozaki CK
Ann Vasc Surg; 2007 Sep; 21(5):598-602. PubMed ID: 17521872
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications.
Ozaki CK; Hamdan AD; Barshes NR; Wyers M; Hevelone ND; Belkin M; Nguyen LL
J Vasc Surg; 2015 Feb; 61(2):419-427.e1. PubMed ID: 25175629
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
[TBL] [Abstract][Full Text] [Related]
4. Occlusive vs gauze dressings for local wound care in surgical patients: a randomized clinical trial.
Ubbink DT; Vermeulen H; Goossens A; Kelner RB; Schreuder SM; Lubbers MJ
Arch Surg; 2008 Oct; 143(10):950-5. PubMed ID: 18936373
[TBL] [Abstract][Full Text] [Related]
5. Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing.
Asz J; Asz D; Moushey R; Seigel J; Mallory SB; Foglia RP
J Pediatr Surg; 2006 Dec; 41(12):e9-12. PubMed ID: 17161178
[TBL] [Abstract][Full Text] [Related]
6. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
[TBL] [Abstract][Full Text] [Related]
7. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
9. Negative pressure wound therapy for at-risk surgical closures in patients with multiple comorbidities: a prospective randomized controlled study.
Masden D; Goldstein J; Endara M; Xu K; Steinberg J; Attinger C
Ann Surg; 2012 Jun; 255(6):1043-7. PubMed ID: 22549748
[TBL] [Abstract][Full Text] [Related]
10. Use of Acticoat dressings in burns: what is the evidence?
Khundkar R; Malic C; Burge T
Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
[TBL] [Abstract][Full Text] [Related]
11. A case report of the use of nanocrystalline silver dressing in the management of acute surgical site wound infected with MRSA to prevent cutaneous necrosis following revision surgery.
Bhattacharyya M; Bradley H
Int J Low Extrem Wounds; 2008 Mar; 7(1):45-8. PubMed ID: 18372271
[TBL] [Abstract][Full Text] [Related]
12. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.
Tredget EE; Shankowsky HA; Groeneveld A; Burrell R
J Burn Care Rehabil; 1998; 19(6):531-7. PubMed ID: 9848045
[TBL] [Abstract][Full Text] [Related]
13. Acticoat dressings and major burns: systemic silver absorption.
Moiemen NS; Shale E; Drysdale KJ; Smith G; Wilson YT; Papini R
Burns; 2011 Feb; 37(1):27-35. PubMed ID: 20961690
[TBL] [Abstract][Full Text] [Related]
14. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study.
Innes ME; Umraw N; Fish JS; Gomez M; Cartotto RC
Burns; 2001 Sep; 27(6):621-7. PubMed ID: 11525858
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of hydrocolloid dressings for neurosurgical wounds.
Fujimoto Y; Shimooka N; Ohnishi Y; Yoshimine T
Surg Neurol; 2008 Aug; 70(2):217-20; discussion 220. PubMed ID: 18262632
[TBL] [Abstract][Full Text] [Related]
16. Acticoat versus Allevyn as a split-thickness skin graft donor-site dressing: a prospective comparative study.
Argirova M; Hadjiski O; Victorova A
Ann Plast Surg; 2007 Oct; 59(4):415-22. PubMed ID: 17901734
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of antimicrobial activity of slow release silver nanoparticles dressing in post-cardiac surgery mediastinitis.
Totaro P; Rambaldini M
Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):153-4. PubMed ID: 18948308
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
Huang Y; Li X; Liao Z; Zhang G; Liu Q; Tang J; Peng Y; Liu X; Luo Q
Burns; 2007 Mar; 33(2):161-6. PubMed ID: 17175106
[TBL] [Abstract][Full Text] [Related]
19. A retrospective cohort study of Acticoat versus Silvazine in a paediatric population.
Cuttle L; Naidu S; Mill J; Hoskins W; Das K; Kimble RM
Burns; 2007 Sep; 33(6):701-7. PubMed ID: 17644258
[TBL] [Abstract][Full Text] [Related]
20. Suprathel-acetic acid matrix versus acticoat and aquacel as an antiseptic dressing: an in vitro study.
Ryssel H; Germann G; Riedel K; Reichenberger M; Hellmich S; Kloeters O
Ann Plast Surg; 2010 Oct; 65(4):391-5. PubMed ID: 20798627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
